Table 3. Subjects Experiencing at Least One Unsolicited or Solicited Adverse Events (FAS, N = 632).
Subject based | Diagnosed AD (N = 350) n (%) | Healthy (N = 282) n (%) | P-value |
---|---|---|---|
At least one AE documented | 331 (94.6) | 268 (95.0) | 0.858 |
SAE in active study period | 1 (0.3) | 2 (0.7) | 0.589 |
AESI | 58 (16.6) | 38 (13.5) | 0.316 |
AE leading to withdrawal from study | 0 (0.0) | 1 (0.4) | 0.446 |
Causally related AE | 236 (67.4) | 168 (59.6) | 0.046 |
Causally related AE graded ≥ 3 | 27 (7.7) | 16 (5.7) | 0.343 |
N = number of subjects in the specified group; n = number of subjects in the specified category (with at least one adverse event); % = percentages of n based on N; AD = atopic dermatitis; AE = adverse event; AESI = adverse event of special interest; SAE = serious adverse event; related AE = AE considered by the investigator to have a possible, probable, definite or missing relationship to study medication; Grade ≥ 3 = AE which prevented normal everyday activities or body temperature ≥ 39°C; FAS = full analysis set. P-value is Fisher’s exact test of the differences in proportions between groups.